This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Veracyte (VCYT) Soars 7.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Veracyte (VCYT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
VCYTPositive Net Change TMDXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Broadridge Financial (BR): Can Its 4.3% Jump Turn into More Strength?
by Zacks Equity Research
Broadridge Financial (BR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BRNegative Net Change BRZENegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
SIGMA LITHIUM (SGML) Soars 6.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
SIGMA LITHIUM (SGML) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SGMLNo Net Change HAYWNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Bowman Consulting (BWMN) Soars 5.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Bowman Consulting (BWMN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
BWMNNegative Net Change ZIPPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Stevanato (STVN) Soars 10.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Stevanato (STVN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
STVNPositive Net Change ONCPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Coya Therapeutics, Inc. (COYA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
COYAPositive Net Change ABSIPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Raymond James Financial, Inc. (RJF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
RJFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
CryoPort, Inc. (CYRX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
CYRXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Alphabet (GOOGL) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
GOOGLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Ur Energy (URG) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
URGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Envista (NVST)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
NVSTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
City Office REIT (CIO) Surges 24.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
City Office REIT (CIO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in FFO estimate revisions may not translate into further price increase in the near term.
CIONo Net Change LANDPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
scPharmaceuticals (SCPH) Soars 8.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
scPharmaceuticals (SCPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SCPHPositive Net Change CLDXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Tree.com (TREE) Surges 22.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Tree.com (TREE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
TREEPositive Net Change UWMCPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
HighPeak Energy (HPK) Moves 7.4% Higher: Will This Strength Last?
by Zacks Equity Research
HighPeak Energy (HPK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
HPKNegative Net Change GPORNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Pixelworks (PXLW) Moves 20.8% Higher: Will This Strength Last?
by Zacks Equity Research
Pixelworks (PXLW) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
PXLWPositive Net Change SVCONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Shutterstock (SSTK) Surges 9.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Shutterstock (SSTK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SSTKPositive Net Change GENIPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Wolverine (WWW) Surges 7.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Wolverine (WWW) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
WWWPositive Net Change ADDYYPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
BioHarvest Sciences Inc. (BHST) Surges 5.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
BioHarvest Sciences Inc. (BHST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BHSTNegative Net Change RARENegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
CorMedix (CRMD) Soars 5.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
CorMedix (CRMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CRMDNegative Net Change ILMNNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Coherent (COHR) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
COHRPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Preferred Bank (PFBC)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
PFBCPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
United Therapeutics (UTHR) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
UTHRNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
SoFi Technologies, Inc. (SOFI) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
SOFINegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Hewlett Packard Enterprise (HPE) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
HPEPositive Net Change
daily-movers moving-average-crossover stocks-moving-today